On June 23, the Council of Ministers agreed to provide 100.0 million ($154.8 million) from the European Union's Seventh Framework Program (FP7) budget to Eurostars, a R&D program jointly set up by 31 countries to boost research capacities of small and medium-sized companies (SMEs) in Europe. The amount from the FP7 will leverage at least 300.0 million euros in public funding from the participating countries, resulting in a package of 400.0 million euros for financing trans-national research partnerships driven research-performing SMEs in Europe, says a European Commission statement.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze